Commission Actions

Show: 20 | 50 | 100
Displaying 20 results
Displaying 101 - 120 of 30610

Pages

February 22, 2019

Press Release: FTC Approves Application from Praxair and Linde for Sale of an Industrial Gases Plant to LyondellBasell Acetyls, LLC
Press Release: FTC Announces Agenda for the Tenth Session of its Hearings on Competition and Consumer Protection in the 21st Century
Press Release: FTC Approves Final Order Imposing Conditions on Penn National Gaming, Inc.’s Acquisition of Pinnacle Entertainment, Inc.
Closing Letter: 3D Solutech, Inc.
Matter Number: P074204
Case: Benco/Schein/Patterson, In the Matter of
Matter Number: 151 0190
Case: Allergan, Watson and Endo
Matter Number: 141 0004
Case: Watson Pharmaceuticals, Inc., et al. (FTC v. Actavis)
Matter Number: 071 0060
Case: Linde AG and Praxair, Inc., In the Matter of
Matter Number: 171 0068
Case: Penn National Gaming and Pinnacle Entertainment, In the Matter of
Matter Number: 181 0011

February 21, 2019

Press Release: FTC Approves Final Consent Order against Company and Owner Who Allegedly Made Unsupported Health Claims for Intravenously Injected Therapy Products
Case: Benco/Schein/Patterson, In the Matter of
Matter Number: 151 0190
Case: A&O Enterprises, doing business as iV Bars, and Aaron K. Roberts, In the Matter of
Matter Number: 172 3016

February 19, 2019

Public Statement: Statement of Chairman Simons, Commissioner Phillips, and Commissioner Wilson Concerning the Proposed Acquisition of NxStage Medical, Inc. by Fresenius Medical Care AG & Co. KGaA
Matter Number: 171 0227
Public Statement: Statement of Commissioner Chopra In the Matter of Fresenius Medical Care AG & Co. KGaA and NxStage Medical, Inc.
Matter Number: 171 0227
Public Statement: Statement of Commissioner Slaughter In the Matter of Fresenius Medical Care AG & Co. KGaA and NxStage Medical, Inc.
Matter Number: 171 0227
Press Release: FTC Requires Fresenius Medical Care AG & KGaA and NxStage Medical, Inc. to Divest Bloodline Tubing Assets to B. Braun Medical, Inc. as a Condition of Merger
Press Release: FTC Enters Global Settlement to Resolve Reverse-Payment Charges against Teva
Public Event: Cmr. Wilson keynote at the GCR Live 8th Annual Antitrust Law Leaders Forum
Case: Cephalon, Inc.
Matter Number: 061 0182
Case: Fresenius Medical Care and NxStage Medical, In the Matter of
Matter Number: 171 0227

Pages